In the mRNA vaccine maker’s 2024 Shareholder Letter, CEO Stéphane Bancel reflected upon the company’s second year ...

Sanofi will build a €1 billion ($1.1 billion) mAb production facility in Vitry-sur-Seine, while it invests €100 million to bolster capacity at its Le Trait site in Normandy and invests €10 million at ...

Articles In Color Color reprints are printed on 70# enamel paper and can be reproduced in color or in black and white. Color articles reprinted in black and white will be charged black and white ...

Contract development and manufacturing organization (CDMO) Celltechna, a part of the Northway Group, has broken ground on a gene therapy center in Vilnius, Lithuania. The €50 million ($54 million) ...

Announced in 2021, the facility, named Modulus, is expected to be fully operational by 2026 and will create about 200 jobs locally. Modulus is Sanofi’s first "EVolutive vaccine facility (EVF)" outside ...

According to the contract development and manufacturing organization (CDMO), the 18,000 square-meter headquarters spans over five floors, employing more than 600 people. “Our company headquarters were ...

Indian pharmaceutical company Intas Pharmaceuticals signed a deal to acquire Udenyca, a bone marrow stimulant used to treat low white blood-cell counts in patients who take cancer medications. Accord ...

Founded in the middle of 2002, BPI published its first issue in January of 2003. Our 20th-anniversary issue thus takes the form of a state-of-the-early-21st-century industry report. Assembling this ...

Cell line development involves the screening of thousands of clones in an effort to find the few optimal clones that are stable, grow as expected, and produce high yields of the bioproduct. The time ...

Resilience, the contract development and manufacturing organization (CDMO) in all-but-name that launched in November 2019, has laid plans to expand fill and finish facilities in Cincinnati, Ohio and ...

Glucagon-like peptide-1 (GLP-1) drugs for diabetes and weight loss are emerging as the latest blockbuster pharmaceuticals. Like messenger RNA (mRNA) gaining recognition during the pandemic, the ...